Enhanced myocardial washout and retrograde blood delivery with synchronized retroperfusion during acute myocardial ischemia
BL Chang,
JK Drury,
S Meerbaum,
MC Fishbein,
JS Whiting,
and
E Corday
The effects of synchronized coronary venous retroperfusion of arterial blood on myocardial washout were studied with digital subtraction angiography in 10 closed chest dogs during balloon occlusion of the proximal left anterior descending coronary artery. The center lumen of the intracoronary balloon catheter was used for sequential injections of 1 ml (meglumine diatrizoate) Renografin-76, and contrast washout rate was determined by videodensitometry in myocardial regions subserved by the left anterior descending coronary artery. Before coronary artery occlusion, washout rate was 22.4 +/- 2.7 min-1 (mean +/- SEM). Five minutes after occlusion, and immediately before synchronized retroperfusion, washout rate dropped sharply to 2.0 +/- 0.7 min-1. Twenty-five minutes after occlusion, with 50 ml/min synchronized retroperfusion treatment applied for 5 minutes, washout rate was 5.0 +/- 1.5 min-1. Thus, synchronized retroperfusion significantly (p less than 0.05) accelerated contrast disappearance over that during presynchronized retroperfusion ischemia. To determine the effects of synchronized retroperfusion on retrograde delivery to the ischemic myocardium, monastral blue dye was retroinfused through the system into the great cardiac vein before the dog was killed. Transverse heart slices were then studied by light microscopy, and regional intravascular dye content was scored from 0 to 3 (0 = no dye, 3 = maximal dye). After great cardiac vein synchronized retroperfusion, blue dye content in capillaries of ischemic anterior and nonischemic posterior aspects of the left ventricle was 2.3 +/- 0.5 versus 0.7 +/- 0.3, respectively (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
|
|
 
J.-C. Corvol, J.-B. Anzouan-Kacou, E. Fauveau, A.-M. Bonnet, B. Lebrun-Vignes, C. Girault, Y. Agid, P. Lechat, R. Isnard, and L. Lacomblez
Heart Valve Regurgitation, Pergolide Use, and Parkinson Disease: An Observational Study and Meta-analysis
Arch Neurol,
December 1, 2007;
64(12):
1721 - 1726.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Pecher and B. A. Schumacher
Angiogenesis in ischemic human myocardium: clinical results after 3 years
Ann. Thorac. Surg.,
May 1, 2000;
69(5):
1414 - 1419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Martin, J. G. Byrne, O. Y. Ghez, U. Sayeed-Shah, S. D. Grachev, R. G. Laurence, and L. H. Cohn
LV-powered coronary sinus retroperfusion reduces infarct size in acutely ischemic pigs
Ann. Thorac. Surg.,
January 1, 2000;
69(1):
84 - 89.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Schumacher, P. Pecher, B. U. von Specht, and Th. Stegmann
Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth Factors : First Clinical Results of a New Treatment of Coronary Heart Disease
Circulation,
February 24, 1998;
97(7):
645 - 650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Aldea, X. Zhang, S. Rivers, and R. J. Shemin
Salvage of Ischemic Myocardium With Simplified and Even Delayed Coronary Sinus Retroperfusion
Ann. Thorac. Surg.,
July 1, 1996;
62(1):
9 - 15.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. Johnson and T. Ports
Unstable Angina Pectoris: An Interventional Approach to Management
J Intensive Care Med,
July 1, 1988;
3(4):
202 - 214.
[Abstract]
[PDF]
|
|
|
|
